Ionis Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Ionis Pharmaceuticals patents 237 in total
Status | Patent |
---|---|
Application | Utility: MODULATORS OF IRF4 EXPRESSION Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Grant | Utility: Compounds and methods for modulating angiotensinogen expression Filling date: 8 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Methods for reducing LRRK2 expression Filling date: 8 Sep 2025 Issue date: 2 Feb 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN Filling date: 8 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: MODIFIED COMPOUNDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: Selective Antisense Compounds and Uses Thereof Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: METHODS FOR MODULATING FMR1 EXPRESSION Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: MODULATION OF HSD17B13 EXPRESSION Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 |
Grant | Utility: Compositions and methods for modulating apolipoprotein (a) expression Filling date: 8 Sep 2025 Issue date: 5 Jan 2021 |
Application | Utility: METHODS OF MODULATING ANTISENSE ACTIVITY Filling date: 8 Sep 2025 Issue date: 31 Dec 2020 |
Grant | Utility: Compositions and methods for modulating angiopoietin-like 3 expression Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 |
Application | Utility: Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof Filling date: 8 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: MODULATORS OF DNM2 EXPRESSION Filling date: 8 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE Filling date: 8 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING SNCA EXPRESSION Filling date: 8 Sep 2025 Issue date: 17 Dec 2020 |
Grant | Utility: Modulators of DNM2 expression Filling date: 8 Sep 2025 Issue date: 15 Dec 2020 |
Grant | Utility: Oligomeric compounds comprising .alpha.-.beta.-constrained nucleic acid Filling date: 8 Sep 2025 Issue date: 15 Dec 2020 |
Application | Utility: 5' MODIFIED NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 |
Grant | Utility: Methods for treating hypercholesterolemia Filling date: 8 Sep 2025 Issue date: 8 Dec 2020 |
Application | Utility: Selective Reduction of Allelic Variants Filling date: 8 Sep 2025 Issue date: 3 Dec 2020 |
Grant | Utility: Modulation of SMN expression Filling date: 8 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Conjugated antisense compounds and their use Filling date: 8 Sep 2025 Issue date: 24 Nov 2020 |
Application | Utility: MODULATING APOLIPOPROTEIN (A) EXPRESSION Filling date: 8 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) Expression Filling date: 8 Sep 2025 Issue date: 19 Nov 2020 |
Grant | Utility: Modulation of huntingtin expression Filling date: 8 Sep 2025 Issue date: 17 Nov 2020 |
Grant | Utility: Compounds and methods for the modulation of proteins Filling date: 8 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Compositions for modulating C9ORF72 expression Filling date: 8 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Modulation of alpha synuclein expression Filling date: 8 Sep 2025 Issue date: 27 Oct 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING ATAXIN 3 EXPRESSION Filling date: 8 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: COMPOSITIONS AND THEIR USES DIRECTED TO HUNTINGTIN Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: CANCER TREATMENT Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Grant | Utility: Compositions and methods for modulating growth hormone receptor expression Filling date: 8 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Compositions for modulating expression of C9ORF72 antisense transcript Filling date: 8 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: COMBINATIONS FOR THE MODULATION OF SMN EXPRESSION Filling date: 8 Sep 2025 Issue date: 1 Oct 2020 |
Grant | Utility: Modulators of PNPLA3 expression Filling date: 8 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Modulation of Factor 11 expression Filling date: 8 Sep 2025 Issue date: 15 Sep 2020 |
Application | Utility: MODULATORS OF MALAT1 EXPRESSION Filling date: 8 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: ANTISENSE COMPOUNDS Filling date: 8 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODULATING APOLIPOPROTEIN (A) EXPRESSION Filling date: 8 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: 2'-METHOXY SUBSTITUTED OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATIONS Filling date: 8 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: Single-Stranded RNAI Oligonucleotides Targeting APOC-III Filling date: 8 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: MODULATION OF HUNTINGTIN EXPRESSION Filling date: 8 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 27 Aug 2020 |
Grant | Utility: Method for synthesis of reactive conjugate clusters Filling date: 8 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Compounds and methods for detecting oligonucleotides Filling date: 8 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Methods of predicting toxicity Filling date: 8 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Compositions and their uses directed to huntingtin Filling date: 8 Sep 2025 Issue date: 11 Aug 2020 |
Application | Utility: Compositions for Modulating Expression of C9ORF72 Antisense Transcript Filling date: 8 Sep 2025 Issue date: 30 Jul 2020 |
Showing 100 to 150 of 237 patents.